NR1H3 and atherosclerosis: Moreover, our results also showed that IGFBPL1 inhibits macrophage lipid accumulation by enhancing the activation of IGR-1R/LXRα/ABCG1 pathway (Figure 5), suggesting that targeting IGFBPL1 may be an effective therapy for atherosclerosis.